Laura Suter-Dick

Institution: FHNW

Address:

Gründenstrasse 40 4132 Muttenz

Email: laura.suterdick@fhnw.ch

Group website: www.fhnw.ch/de/forschung-und-dienstleistungen/lifesciences/chemie-und-bioanalytik/zellbiologie-und-in-vitro-toxikologie

Phone: 0612285659

Research interests:

3D in vitro cell cultures models (liver, kidney, breast cancer cells) Toxicology Drug Discovery Molecular biology Cell biology Tissue engineering

Selected publications:

1. R. M. Kostadinova, et al. A Long-Term Three Dimensional Liver Co-Culture System for Improved Prediction of Clinically Relevant Drug-Induced Hepatotoxicity. Tox. Appl. Pharmacol., 268: 1-16 (2013). 2. T. M. DesRochers, et al. Bioengineered 3D Human Kidney Tissue, a Platform for the Determination of Nephrotoxicity. PLOS One. ePub (2013) 3. L. Suter-Dick, et al. Stem cell derived (SCD) systems in toxicology assessment. Stem Cells and Development, 2015. e-print.. 4. MJ Wilmer, et al. Kidney-on-a-Chip Technology for Drug-Induced Nephrotoxicity Screening. Trends in Biotechnology, Vol. 34, No. 2 (2016) 5. F.A. Atienzar, et al. Key challenges and opportunities associated with the use of in vitro models to detect human DILI: integrated risk assessment and mitigation plans. BMRI 2016:9737920 (2016). 6. V. Prestigiacomo, et al. Pro-Fibrotic Compounds Induce Stellate Cell Activation, ECM-Remodelling and Nrf2 Activation in a Human 3D-Multicellular Model of Liver Fibrosis. PLOS One, 12 (6) (2017). 7. Poster: 3D-cultures of MCF-7 cells resemble tumor phenotype. Salvatore Mannino, Laura Suter-Dick. TEDD Annual meeting 2016, Wädenswil, Switzerland.(manuscript in preparation)

Members List